Article Text

The first three mosaic cri du chat syndrome patients with two rearranged cell lines
  1. C PERFUMO*,
  2. P CERRUTI MAINARDI,
  3. A CALÌ*,
  4. G COUCOURDE,
  5. F ZARA*,
  6. S CAVANI*,
  7. J OVERHAUSER,
  8. F DAGNA BRICARELLI*,
  9. M PIERLUIGI*
  1. *Human Genetics Laboratory, Galliera Hospital, Via A Volta 10r, 16128 Genova, Italy
  2. †Department of Paediatrics and Genetics, S Andrea Hospital, Vercelli, Italy
  3. ‡Thomas Jefferson University, Philadelphia, PA, USA
  1. Dr Dagna Bricarelli, dagna{at}galliera.it

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Editor—Cri du chat syndrome (CdCS) is one of the more common deletion syndromes, involving the short arm of chromosome 5, with an incidence of 1 in 50 000 live births. Classically, patients with this syndrome present with microcephaly, a round face, hypertelorism, micrognathia, prominent nasal bridge, epicanthic folds, hypotonia, and severe psychomotor retardation. Infants also exhibit a high pitched cry similar to the mewing of a cat, which is usually considered diagnostic for this syndrome.1 2 Recently, genotype-phenotype studies in CdCS led to the identification of two separate chromosomal regions, hemizygosity for which is associated with specific phenotypes.3 A deletion of 5p15.3 results in the manifestation of a cat-like cry4, while a deletion of 5p15.2 results in the presentation of the other major clinical features of the syndrome.5 Moreover, a region for speech delay in 5p15.3 has been identified.6

From a review of 331 published cases, Niebuhr2 estimated that most CdCS cases are the result of de novo deletions (about 80%), some derive from a familial rearrangement (12%), and only a few show other rare cytogenetic aberrations, such as mosaicism (3%), rings (2.4%), and de novo translocations (3%). Chromosomal mosaicism in CdCS has been described involving a cell line with a 5p deletion and a cell line with a normal karyotype.2 7

We describe the first three reported cases of mosaic de novo 5p anomalies involving two rearranged cell lines in CdCS out of 80 (3.75%) patients from the Italian Register of CdCS8analysed in a large study of correlation between 5p deletion and phenotypic effect (Cerruti Mainardi et al, manuscript in preparation).

Patient 1 was the first female child of healthy, unrelated parents. At birth the mother was 29 and the father 31 years old. The pregnancy was …

View Full Text